Clinical Trial Update: AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating AZD2014 in combination with fulvestrant in ER-positive advanced/metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD2014 (vistusertib)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Metastatic Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-17